Thymic T-cell development in allogeneic stem cell transplantation
Open Access
- 23 June 2011
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 117 (25), 6768-6776
- https://doi.org/10.1182/blood-2011-02-334623
Abstract
Cytoreductive conditioning regimens used in the context of allogeneic hematopoietic cell transplantation (HCT) elicit deficits in innate and adaptive immunity, which predispose patients to infections. As such, transplantation outcomes depend vitally on the successful reconstruction of immune competence. Restoration of a normal peripheral T-cell pool after HCT is a slow process that requires the de novo production of naive T cells in a functionally competent thymus. However, there are several challenges to this regenerative process. Most notably, advanced age, the cytotoxic pretransplantation conditioning, and posttransplantation alloreactivity are risk factors for T-cell immune deficiency as they independently interfere with normal thymus function. Here, we discuss preclinical allogeneic HCT models and clinical observations that have contributed to a better understanding of the transplant-related thymic dysfunction. The identification of the cellular and molecular mechanisms that control regular thymopoiesis but are altered in HCT patients is expected to provide the basis for new therapies that improve the regeneration of the adaptive immune system, especially with functionally competent, naive T cells.Keywords
This publication has 101 references indexed in Scilit:
- Molecular and cellular basis of T cell lineage commitmentSeminars in Immunology, 2010
- Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathwaysCurrent Opinion in Pharmacology, 2010
- Emerging strategies to boost thymic functionCurrent Opinion in Pharmacology, 2010
- Decision checkpoints in the thymusNature Immunology, 2010
- AIRE in the thymus and beyondCurrent Opinion in Immunology, 2009
- Thymic involution and immune reconstitutionTrends in Immunology, 2009
- Graft-versus-host diseaseThe Lancet, 2009
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved IssuesTransplantation and Cellular Therapy, 2008
- T cell immune reconstitution following lymphodepletionSeminars in Immunology, 2007
- Lymphoid Reconstruction and VaccinesTransplantation and Cellular Therapy, 2007